Nasdaq: CRBP

Corbus Pharmaceuticals Holdings, Inc. (CRBP)

Corbus Pharmaceuticals Holdings, Inc. is a public company that reports to the U.S. Securities and Exchange Commission and trades on Nasdaq under the ticker CRBP. Bright Analyst brings its financial statements, SEC filings, stock performance, news and peer comparisons together in one place, with AI analysis throughout.

Key facts

Ticker symbol
CRBP
Exchange
Nasdaq
SEC CIK
1595097
Official filings
SEC EDGAR

Research CRBP

  • Profile — Business description, headquarters, subsidiaries and corporate identifiers.
  • Financials — Income statement, balance sheet and cash flow from 10-K and 10-Q filings.
  • SEC Filings — Every 10-K, 10-Q and 8-K, readable inline with AI analysis.
  • Stock Analysis — Price chart, returns, technical indicators and related companies.
  • News — Latest headlines and press coverage.
  • Material Contracts — Material agreements filed as exhibits to SEC reports.
  • Benchmark — Stock performance against the S&P 500, Nasdaq-100 and Dow (through SPY, QQQ and DIA) and economic indicators.
  • Peer Comparison — Side-by-side financial ratios against industry peers.

Frequently asked questions

What is Corbus Pharmaceuticals Holdings, Inc.'s stock ticker?

Corbus Pharmaceuticals Holdings, Inc. trades under the ticker symbol CRBP on Nasdaq. Its SEC Central Index Key (CIK) is 1595097.

Where can I read Corbus Pharmaceuticals Holdings, Inc.'s SEC filings?

The CRBP SEC Filings page lists the 10-K annual reports, 10-Q quarterly reports and 8-K current reports Corbus Pharmaceuticals Holdings, Inc. has filed, with AI analysis. The original documents are also on SEC EDGAR.

How can I analyze CRBP's financial statements?

The CRBP Financials page shows Corbus Pharmaceuticals Holdings, Inc.'s income statement, balance sheet and cash flow statement, annual and quarterly, taken from its XBRL filings, with an AI analysis of each statement.

How does CRBP compare with its peers and the market?

The CRBP Peer Comparison page lines Corbus Pharmaceuticals Holdings, Inc. up against industry peers on valuation, growth and profitability ratios, and the Benchmark page compares its stock with the S&P 500, the Nasdaq-100 and the Dow.

For information only — not investment advice.